左心室辅助装置(LVAD)患者缺血性与出血性卒中的危险因素、死亡率及发生时机
该研究回顾了402例置入HeartMate II或HeartWare左心室辅助装置(LVAD)患者的资料,分析早期(住院期间)和晚期(出院后)缺血性与出血性卒中的预测因素及其与死亡的关系。结果显示卒中发生于69例患者(17%),卒中和死亡风险呈双峰分布,早期出血性卒中、晚期缺血性卒中和晚期出血性卒中均预测死亡,而早期缺血性卒中不预测死亡。
要点
- LVAD患者卒中发生率为17%(0.14事件/患者年),晚期出血性卒中占7%。
- 卒中和死亡风险呈双峰分布:置入后立即最高,9-12个月后再次升高。
- 早期出血性卒中、晚期缺血性卒中和晚期出血性卒中是死亡的独立预测因素。
核心结论
- 卒中(stroke)是左心室辅助装置(LVAD)患者死亡的主要原因和预测因素。
- LVAD患者中卒中和死亡风险呈双峰模式,置入时风险最高,9-12个月后再次升高。
- 管理可改变的危险因素可能降低卒中和死亡率。
研究设计与样本
- 评估早期(住院期间)和晚期(出院后)缺血性与出血性卒中的预测因素,以及卒中亚型与死亡的关系。
主要发现
- 402例患者中共发生83次卒中,涉及69例患者(17%;0.14事件/患者年)。
- 早期缺血性卒中18/402(4%;0.03事件/患者年),早期出血性卒中11/402(3%;0.02事件/患者年)。
- 晚期缺血性卒中25/402(6%;0.04事件/患者年),晚期出血性卒中29/402(7%;0.05事件/患者年)。
- 可改变的卒中危险因素因时机和卒中类型而异,包括吸烟、菌血症、泵血栓、泵感染和高血压(均p<0.05)。
- 多变量分析中,早期出血性卒中(aOR 4.3,95%CI 1.0-17.8,p=0.04)、晚期缺血性卒中(aOR 3.2,95%CI 1.1-9.0,p=0.03)和晚期出血性卒中(aOR 3.7,95%CI 1.5-9.2,p=0.005)预测死亡,而早期缺血性卒中不预测死亡。
临床怎么用
- LVAD患者置入后早期和9-12个月时需加强卒中监测与预防。
- 针对可改变危险因素(吸烟、菌血症、泵血栓、泵感染、高血压)进行管理可能降低卒中和死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke is a major cause of mortality after left ventricular assist device (LVAD) placement. METHODS: Prospectively collected data of patients with HeartMate II (n = 332) and HeartWare (n = 70) LVADs from October 21, 2004, to May 19, 2015, were reviewed. Predictors of early (during index hospitalization) and late (post-discharge) ischemic and hemorrhagic stroke and association of stroke subtypes with mortality were assessed. RESULTS: Of 402 patients, 83 strokes occurred in 69 patients (17%; 0.14 events per patient-year [EPPY]): early ischemic stroke in 18/402 (4%; 0.03 EPPY), early hemorrhagic stroke in 11/402 (3%; 0.02 EPPY), late ischemic stroke in 25/402 (6%; 0.04 EPPY) and late hemorrhagic stroke in 29/402 (7%; 0.05 EPPY). Risk of stroke and death among patients with stroke was bimodal with highest risks immediately post-implant and increasing again 9-12 months later. Risk of death declined over time in patients without stroke. Modifiable stroke risk factors varied according to timing and stroke type, including tobacco use, bacteremia, pump thrombosis, pump infection, and hypertension (all p < 0.05). In multivariable analysis, early hemorrhagic stroke (adjusted odds ratio [aOR] 4.3, 95% confidence interval [CI] 1.0-17.8, p = 0.04), late ischemic stroke (aOR 3.2, 95% CI 1.1-9.0, p = 0.03), and late hemorrhagic stroke (aOR 3.7, 95% CI 1.5-9.2, p = 0.005) predicted death, whereas early ischemic stroke did not. CONCLUSIONS: Stroke is a leading cause and predictor of death in patients with LVADs. Risk of stroke and death among patients with stroke is bimodal, with highest risk at time of implant and increasing risk again after 9-12 months. Management of modifiable risk factors may reduce stroke and mortality rates.
引用
- Frontera JA, Starling R, Cho SM, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transplant. 2016. PMID: 28110971. doi:10.1016/j.healun.2016.12.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。